Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Postoperative Pain in Ectopic Pregnancy
NCT06559280Phase 1Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of esketamine in postoperative pain (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Postoperative pain sensitivity at 1 week. Started Aug 2024; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06559280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06559280.